nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylhexedrine—SLC18A2—Neurotransmitter Release Cycle—SLC22A1—prostate cancer	0.0167	0.0167	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.0162	0.0162	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—VIP—prostate cancer	0.0157	0.0157	CbGpPWpGaD
Propylhexedrine—SLC18A2—Dopaminergic Neurogenesis—TH—prostate cancer	0.0151	0.0151	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—PDE4D—prostate cancer	0.0144	0.0144	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—RLN2—prostate cancer	0.0137	0.0137	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—GNG5—prostate cancer	0.0137	0.0137	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—GRPR—prostate cancer	0.012	0.012	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—PTHLH—prostate cancer	0.0119	0.0119	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—CALCA—prostate cancer	0.0105	0.0105	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.0105	0.0105	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—RLN2—prostate cancer	0.0104	0.0104	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—MC2R—prostate cancer	0.00989	0.00989	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.00933	0.00933	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—GRPR—prostate cancer	0.00917	0.00917	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—PENK—prostate cancer	0.00882	0.00882	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—ADRB2—prostate cancer	0.00879	0.00879	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.00853	0.00853	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—KCNN3—prostate cancer	0.0082	0.0082	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—WNT4—prostate cancer	0.0079	0.0079	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—OR51E2—prostate cancer	0.00777	0.00777	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—MC2R—prostate cancer	0.00753	0.00753	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—prostate cancer	0.0075	0.0075	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.00738	0.00738	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—LPAR1—prostate cancer	0.00726	0.00726	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—GRP—prostate cancer	0.00726	0.00726	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—OR51E2—prostate cancer	0.00705	0.00705	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—prostate cancer	0.00705	0.00705	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—PENK—prostate cancer	0.00671	0.00671	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—RRAS—prostate cancer	0.00661	0.00661	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—RGS17—prostate cancer	0.00661	0.00661	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—RGS17—prostate cancer	0.006	0.006	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—RLN2—prostate cancer	0.00589	0.00589	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.00586	0.00586	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.00586	0.00586	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—GNRH1—prostate cancer	0.00571	0.00571	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—LPAR1—prostate cancer	0.00553	0.00553	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—GRP—prostate cancer	0.00553	0.00553	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PLXNB1—prostate cancer	0.00538	0.00538	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—CX3CL1—prostate cancer	0.00537	0.00537	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—RLN2—prostate cancer	0.00535	0.00535	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—ANXA1—prostate cancer	0.00534	0.00534	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—GRPR—prostate cancer	0.00518	0.00518	CbGpPWpGaD
Propylhexedrine—SLC18A2—Dopaminergic Neurogenesis—STAT3—prostate cancer	0.00518	0.00518	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—RRAS—prostate cancer	0.00507	0.00507	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—PLCB2—prostate cancer	0.00501	0.00501	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—GNG5—prostate cancer	0.00497	0.00497	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PLXNB1—prostate cancer	0.00489	0.00489	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—prostate cancer	0.00489	0.00489	CbGpPWpGaD
Propylhexedrine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—prostate cancer	0.0048	0.0048	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—SLC22A1—prostate cancer	0.00478	0.00478	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.00475	0.00475	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.00474	0.00474	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—GRPR—prostate cancer	0.00471	0.00471	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—GNG5—prostate cancer	0.00455	0.00455	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—PTHLH—prostate cancer	0.00433	0.00433	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—MC2R—prostate cancer	0.00426	0.00426	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—prostate cancer	0.00419	0.00419	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—OR51E2—prostate cancer	0.00417	0.00417	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—ANXA1—prostate cancer	0.00407	0.00407	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—ACHE—prostate cancer	0.00405	0.00405	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—WNT4—prostate cancer	0.00405	0.00405	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00388	0.00388	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.00387	0.00387	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—MC2R—prostate cancer	0.00387	0.00387	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—PLCB2—prostate cancer	0.00384	0.00384	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—BMPR1B—prostate cancer	0.00381	0.00381	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—CALCA—prostate cancer	0.00381	0.00381	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PENK—prostate cancer	0.00379	0.00379	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00375	0.00375	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—CXCL12—prostate cancer	0.00372	0.00372	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—SLC22A1—prostate cancer	0.00366	0.00366	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—RGS17—prostate cancer	0.00354	0.00354	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—GNG5—prostate cancer	0.00348	0.00348	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PENK—prostate cancer	0.00345	0.00345	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—GNRH1—prostate cancer	0.00323	0.00323	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—VIP—prostate cancer	0.00323	0.00323	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—ADRB2—prostate cancer	0.00319	0.00319	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—RLN2—prostate cancer	0.00316	0.00316	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—LPAR1—prostate cancer	0.00312	0.00312	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—GRP—prostate cancer	0.00312	0.00312	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—ACHE—prostate cancer	0.0031	0.0031	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PLCB2—prostate cancer	0.00309	0.00309	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00306	0.00306	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CTBP2—prostate cancer	0.00301	0.00301	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—HSD17B1—prostate cancer	0.00301	0.00301	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00298	0.00298	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00298	0.00298	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—PRKACB—prostate cancer	0.00297	0.00297	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PDE4D—prostate cancer	0.00295	0.00295	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—GNRH1—prostate cancer	0.00293	0.00293	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—VIP—prostate cancer	0.00293	0.00293	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PLXNB1—prostate cancer	0.00289	0.00289	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—LPAR1—prostate cancer	0.00284	0.00284	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—GRP—prostate cancer	0.00284	0.00284	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.00283	0.00283	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—COMT—prostate cancer	0.00282	0.00282	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PLCB2—prostate cancer	0.00281	0.00281	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—GNG5—prostate cancer	0.00281	0.00281	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GRPR—prostate cancer	0.00278	0.00278	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—CX3CL1—prostate cancer	0.00275	0.00275	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IL17RD—prostate cancer	0.00269	0.00269	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PDE4D—prostate cancer	0.00268	0.00268	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—GNG5—prostate cancer	0.00255	0.00255	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PTHLH—prostate cancer	0.00244	0.00244	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00242	0.00242	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—WNT4—prostate cancer	0.00239	0.00239	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—JUP—prostate cancer	0.00239	0.00239	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—ANXA1—prostate cancer	0.0023	0.0023	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—RALBP1—prostate cancer	0.00228	0.00228	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MC2R—prostate cancer	0.00228	0.00228	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.00223	0.00223	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PTHLH—prostate cancer	0.00222	0.00222	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PRKACB—prostate cancer	0.00217	0.00217	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—COMT—prostate cancer	0.00216	0.00216	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—CALCA—prostate cancer	0.00215	0.00215	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PPP3CA—prostate cancer	0.00212	0.00212	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—CXCL12—prostate cancer	0.0021	0.0021	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—ANXA1—prostate cancer	0.00209	0.00209	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PENK—prostate cancer	0.00204	0.00204	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.00202	0.00202	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.00197	0.00197	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—CALCA—prostate cancer	0.00195	0.00195	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GHR—prostate cancer	0.00194	0.00194	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PRKCQ—prostate cancer	0.00192	0.00192	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—CXCL12—prostate cancer	0.00191	0.00191	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.00187	0.00187	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NRP1—prostate cancer	0.00186	0.00186	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—ADRB2—prostate cancer	0.0018	0.0018	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—VAV3—prostate cancer	0.00176	0.00176	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PRKCQ—prostate cancer	0.00174	0.00174	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—VIP—prostate cancer	0.00173	0.00173	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GNRH1—prostate cancer	0.00173	0.00173	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—ITPR1—prostate cancer	0.00171	0.00171	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—LPAR1—prostate cancer	0.00168	0.00168	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GRP—prostate cancer	0.00168	0.00168	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PLCB2—prostate cancer	0.00166	0.00166	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—LRP2—prostate cancer	0.00166	0.00166	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—ADRB2—prostate cancer	0.00164	0.00164	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—P4HB—prostate cancer	0.00163	0.00163	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CX3CL1—prostate cancer	0.00163	0.00163	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—VAV3—prostate cancer	0.0016	0.0016	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—HIST1H2BG—prostate cancer	0.0016	0.0016	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.0016	0.0016	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PDE4D—prostate cancer	0.00158	0.00158	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GRB7—prostate cancer	0.00158	0.00158	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—ITPR1—prostate cancer	0.00155	0.00155	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—HIST1H4H—prostate cancer	0.00154	0.00154	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—CXCL8—prostate cancer	0.00154	0.00154	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.00151	0.00151	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.00151	0.00151	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GNG5—prostate cancer	0.00151	0.00151	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.00144	0.00144	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PTHLH—prostate cancer	0.00131	0.00131	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—TGFBR1—prostate cancer	0.00131	0.00131	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—AKR1C3—prostate cancer	0.00129	0.00129	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PRKACB—prostate cancer	0.00128	0.00128	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.00127	0.00127	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—THBS1—prostate cancer	0.00125	0.00125	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PPP3CA—prostate cancer	0.00125	0.00125	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ANXA1—prostate cancer	0.00123	0.00123	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PRKCZ—prostate cancer	0.00121	0.00121	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—RXRA—prostate cancer	0.00121	0.00121	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PIK3CG—prostate cancer	0.00118	0.00118	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FGFR4—prostate cancer	0.00117	0.00117	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PARP1—prostate cancer	0.00117	0.00117	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—MDM2—prostate cancer	0.00116	0.00116	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CALCA—prostate cancer	0.00115	0.00115	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CXCL12—prostate cancer	0.00113	0.00113	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PIK3CG—prostate cancer	0.00107	0.00107	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CASP9—prostate cancer	0.00106	0.00106	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PIK3CD—prostate cancer	0.00104	0.00104	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PRKCQ—prostate cancer	0.00103	0.00103	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NGFR—prostate cancer	0.00103	0.00103	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MAP3K7—prostate cancer	0.00102	0.00102	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FGF10—prostate cancer	0.000978	0.000978	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ADRB2—prostate cancer	0.000968	0.000968	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—JAK2—prostate cancer	0.000954	0.000954	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—MAP2K1—prostate cancer	0.000951	0.000951	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PIK3CD—prostate cancer	0.000944	0.000944	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—VAV3—prostate cancer	0.000944	0.000944	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—TGFBR2—prostate cancer	0.00093	0.00093	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000922	0.000922	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ITPR1—prostate cancer	0.000915	0.000915	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PIK3CB—prostate cancer	0.000907	0.000907	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IGF1R—prostate cancer	0.000875	0.000875	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—CXCL8—prostate cancer	0.000871	0.000871	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—JAK2—prostate cancer	0.000867	0.000867	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—LPL—prostate cancer	0.000839	0.000839	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—IL2—prostate cancer	0.000833	0.000833	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PDGFRB—prostate cancer	0.000831	0.000831	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PIK3CB—prostate cancer	0.000823	0.000823	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ITGB3—prostate cancer	0.00081	0.00081	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—CXCL8—prostate cancer	0.000791	0.000791	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ERBB3—prostate cancer	0.000786	0.000786	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FGFR2—prostate cancer	0.000785	0.000785	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—IL2—prostate cancer	0.000756	0.000756	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—TERT—prostate cancer	0.000753	0.000753	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000732	0.000732	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—HIF1A—prostate cancer	0.00072	0.00072	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—LEP—prostate cancer	0.000703	0.000703	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CAV1—prostate cancer	0.000697	0.000697	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—KDR—prostate cancer	0.000689	0.000689	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ESR1—prostate cancer	0.000671	0.000671	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—BAD—prostate cancer	0.000655	0.000655	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PIK3CG—prostate cancer	0.000635	0.000635	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—APC—prostate cancer	0.000635	0.000635	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—EGF—prostate cancer	0.000627	0.000627	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IRS1—prostate cancer	0.000627	0.000627	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GSK3B—prostate cancer	0.000609	0.000609	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—INS—prostate cancer	0.000601	0.000601	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CREBBP—prostate cancer	0.000588	0.000588	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IGF1—prostate cancer	0.000581	0.000581	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—EGFR—prostate cancer	0.000578	0.000578	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MAP2K1—prostate cancer	0.000562	0.000562	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PIK3CD—prostate cancer	0.000558	0.000558	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PIK3CA—prostate cancer	0.000553	0.000553	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—SERPINE1—prostate cancer	0.000552	0.000552	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—KRAS—prostate cancer	0.000546	0.000546	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FGF2—prostate cancer	0.000534	0.000534	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NOS3—prostate cancer	0.000527	0.000527	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—JAK2—prostate cancer	0.000512	0.000512	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PIK3CA—prostate cancer	0.000502	0.000502	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MDM2—prostate cancer	0.0005	0.0005	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ERBB2—prostate cancer	0.000493	0.000493	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PIK3CB—prostate cancer	0.000486	0.000486	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CXCL8—prostate cancer	0.000467	0.000467	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CDKN1B—prostate cancer	0.000456	0.000456	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—AKT1—prostate cancer	0.000451	0.000451	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CASP3—prostate cancer	0.000447	0.000447	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IL2—prostate cancer	0.000447	0.000447	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—IL6—prostate cancer	0.000444	0.000444	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CCND1—prostate cancer	0.000435	0.000435	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CTNNB1—prostate cancer	0.000431	0.000431	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MMP9—prostate cancer	0.000423	0.000423	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CDKN1A—prostate cancer	0.000421	0.000421	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PTEN—prostate cancer	0.00042	0.00042	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—AKT1—prostate cancer	0.00041	0.00041	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—EP300—prostate cancer	0.000401	0.000401	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—SRC—prostate cancer	0.00039	0.00039	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—VEGFA—prostate cancer	0.00038	0.00038	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—STAT3—prostate cancer	0.000376	0.000376	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MYC—prostate cancer	0.000349	0.000349	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—TGFB1—prostate cancer	0.000348	0.000348	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—EGFR—prostate cancer	0.000342	0.000342	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—KRAS—prostate cancer	0.000323	0.000323	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PIK3CA—prostate cancer	0.000296	0.000296	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—TP53—prostate cancer	0.000287	0.000287	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IL6—prostate cancer	0.000263	0.000263	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—AKT1—prostate cancer	0.000242	0.000242	CbGpPWpGaD
